These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29496022)

  • 41. Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.
    Obermeit LC; Cattie JE; Bolden KA; Marquine MJ; Morgan EE; Franklin DR; Atkinson JH; Grant I; Woods SP;
    Addict Behav; 2013 Dec; 38(12):2874-8. PubMed ID: 24018233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Personality traits and mental health states of methamphetamine-dependent and methamphetamine non-using MSM.
    Solomon TM; Kiang MV; Halkitis PN; Moeller RW; Pappas MK
    Addict Behav; 2010 Feb; 35(2):161-3. PubMed ID: 19786324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine.
    Melo P; Moreno VZ; Vázquez SP; Pinazo-Durán MD; Tavares MA
    Brain Res; 2006 Aug; 1106(1):21-29. PubMed ID: 16842764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sexually transmitted infection prevalence and related risk factors among heterosexual male methamphetamine users in China.
    Liu D; Jiang Z; Xiu C; Li Z; Song Q; Wang Z
    Int J STD AIDS; 2017 Oct; 28(12):1208-1214. PubMed ID: 28178893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
    Callaghan RC; Cunningham JK; Sajeev G; Kish SJ
    Mov Disord; 2010 Oct; 25(14):2333-9. PubMed ID: 20737543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of Cardiovascular Diseases and Stroke Events in Methamphetamine Users: A 10-Year Follow-Up Study.
    Huang MC; Yang SY; Lin SK; Chen KY; Chen YY; Kuo CJ; Hung YN
    J Clin Psychiatry; 2016 Oct; 77(10):1396-1403. PubMed ID: 27574836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Characteristics of Fatal Methamphetamine-related Stroke: A National Study.
    Darke S; Lappin J; Kaye S; Duflou J
    J Forensic Sci; 2018 May; 63(3):735-739. PubMed ID: 28833107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context.
    Vos PJ; Cloete KJ; le Roux A; Kidd M; Jordaan GP
    Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):390-4. PubMed ID: 21390410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.
    Reddy PKV; Ng TMH; Oh EE; Moady G; Elkayam U
    J Am Heart Assoc; 2020 Jun; 9(11):e016704. PubMed ID: 32468897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal Methamphetamine: A Drug and Cardiovascular Epidemic.
    Ben-Yehuda O; Siecke N
    JACC Heart Fail; 2018 Mar; 6(3):219-221. PubMed ID: 29496023
    [No Abstract]   [Full Text] [Related]  

  • 51. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study.
    Yen CF; Chong MY
    Compr Psychiatry; 2006; 47(3):215-20. PubMed ID: 16635651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A commentary on the effects of methamphetamine and the status of methamphetamine abuse among youths in South Korea, Japan, and China.
    Kwon NJ; Han E
    Forensic Sci Int; 2018 May; 286():81-85. PubMed ID: 29567545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soda Consumption Among Methamphetamine Users in the USA: Impact on Oral Health.
    Murphy DA; Harrell L; Fintzy R; Vitero S; Gutierrez A; Shetty V
    Oral Health Prev Dent; 2016; 14(3):227-34. PubMed ID: 26870851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two-year outcomes of treatment for methamphetamine use.
    Brecht ML; Greenwell L; von Mayrhauser C; Anglin MD
    J Psychoactive Drugs; 2006 Nov; Suppl 3():415-26. PubMed ID: 17357533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor.
    Liu M; Wang Y; Wang HM; Bai Y; Zhang XH; Sun YX; Wang HL
    Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):77-82. PubMed ID: 22900600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
    Plüddemann A; Dada S; Parry CD; Kader R; Parker JS; Temmingh H; van Heerden S; de Clercq C; Lewis I
    Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):45-9. PubMed ID: 23417636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Orthopaedic Injury Profiles in Methamphetamine Users: A Retrospective Observational Study.
    Trasolini N; Kang H; Carney J; Rounds A; Murrietta A; Marecek GS
    J Am Acad Orthop Surg; 2020 Jan; 28(1):e28-e33. PubMed ID: 30985479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
    Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
    Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrocardiographic abnormalities in methamphetamine abusers.
    Haning W; Goebert D
    Addiction; 2007 Apr; 102 Suppl 1():70-5. PubMed ID: 17493055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.